M4MM

FDA Advisory Panel to Review MDMA for PTSD Treatment

LOS ANGELES- Earlier today, staff from the U.S. Food and Drug Administration (FDA) expressed concerns regarding the interpretation of data from trials on the psychedelic drug MDMA for treating post-traumatic stress disorder (PTSD). These concerns ...

Cardiol Therapeutics Closes $22 Million Bought Deal Offering

ONTARIO–Cardiol Therapeutics Inc. (TSX: CRDL), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease, is pleased to announce the closing of its previously announced "bought deal" short form prospectus ...

Aleafia Health Reports 2021 First Quarter Results

TORONTO–Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) reported its financial results for the three months ended March 31, 2021. “This quarter saw us achieve important executional breakthroughs as we realized the exponential increase of our ...

TerrAscend Opens Largest Apothecarium on the East Coast

NEW YORK and TORONTO–TerrAscend Corp. (CSE:TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced the grand opening of its second New Jersey medical cannabis dispensary. The 6,500 square foot dispensary, located at 1865 ...

Subscribe To Our Newsletter